top of page
Subscribe
Latest
All News
Podcast
Events
Directory
Contact
More
Use tab to navigate through the menu items.
Browse by category
All Posts
All News
Research
Spotlight
Industry & Products
Events & Training
Journal watch
Surgery News
Latest News
Top 10
Search
Protagonist selects PN-477 an oral and injectable triple agonist peptide development candidate for obesity
Protagonist Therapeutics has selected PN-477 a novel oral peptide - PN-477o with once-daily dosing, high potency and activation of...
Browse by tag
obesity
(332)
332 posts
bariatric surgery
(193)
193 posts
type 2 diabetes
(99)
99 posts
weight loss
(84)
84 posts
bariatric and metabolic surgery
(77)
77 posts
semaglutide
(69)
69 posts
glucagon-like peptide (GLP-1) analogues
(58)
58 posts
SOARD
(47)
47 posts
covid-19
(40)
40 posts
adolescent obesity
(38)
38 posts
Obesity Surgery
(38)
38 posts
Journal watch
(37)
37 posts
diabetes
(35)
35 posts
childhood obesity
(35)
35 posts
product launch
(29)
29 posts
laparoscopic sleeve gastrectomy
(28)
28 posts
weight gain
(27)
27 posts
tirzepatide
(24)
24 posts
pregnancy
(23)
23 posts
product approval
(23)
23 posts
metabolic disease
(22)
22 posts
Journal Watch 20/8/2025
1 hour ago
VENTURE-Oral Dosing trial: 80% of patients achieve ≥10% weight loss
2 days ago
FDA approves Wegovy for MASH with moderate to advanced liver fibrosis
2 days ago
Back to Top
bottom of page